epitope corresponding to amino acids 1-227 representing full length TREM-2 of mouse origin
Modification Notes
Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL), known as "Nasu-Hakola disease," is a recessively inherited disease where individuals display early-onset progressive dementia and bone cysts, which leads to death (1,2). Mutations in TYROBP (DAP12), which codes for a membrane receptor component in natural-killer and myeloid cells and mutations in triggering receptor expressed on myeloid cells-2 (TREM-2), correlate well to the pathology of PLOSL (2,3). TREM-2 is a cell surface receptor on human monocyte-derived dendritic cells that forms a receptor signaling complex with DAP12 and triggers activation of the immune response in macrophages and dendritic cells (DC) (2–4). The TREM-2/DAP12 complex is a molecular promoter of upregulation of CC chemokine receptor 7, partial DC maturation, and DC survival through activation of protein tyrosine kinases and extracellular signal-regulated kinase (3,4). The human chronic inflammatory TREM-2 gene maps to chromosome 6p21.1 and encodes a 230 amino acid protein (5).
Key Feature
Clonality
Polyclonal
Isotype
IgG
Host Species
Rabbit
Tested Applications
WBIPIFELISA
recommended for detection of TREM-2 isoforms 1 and 2 of mouse and rat origin by WB, IP, IF and ELISA:
Species Reactivity
HumanMouseRat
Concentration
1mg/ml
Purification
Affinity purified
Target Information
Alternative Names
epitope corresponding to amino acids 1-227 representing full length TREM-2 of mouse origin
Tissue Specificity
epitope corresponding to amino acids 1-227 representing full length TREM-2 of mouse origin